A clinical trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control.
The New York State Senate has honored Tashara M. Leak, associate professor and associate dean of Cornell Human Ecology in New York City, as a 2025 Woman of Distinction.
Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.
Eventual proof of a clear association between genes that express a salivary enzyme and Type 2 diabetes could lead to genetically testing people at birth to predict their susceptibility.
The threat of mosquito-borne diseases, which climate change is expected to exacerbate, highlights local politics’ pivotal and understudied role in public health.
The Riney Canine Health Center embodies a complete approach to canine health, combining innovative research with community engagement and education. The Bark in the Parkserves as the most recent exampleof how the center is connecting researchers, veterinarians and dog enthusiasts to ensure that every advancement in canine health contributes meaningfully to the lives of dogs.
Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports the way we think and act.
At their spring banquet, students in the Robert S. Harrison College Scholar Program hear from a speaker who helps foster creative and critical thinking skills.
A new material developed at Cornell could significantly improve the delivery and effectiveness of mRNA vaccines – used to fight COVID-19 – by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.